- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00447655
Improving Outcomes Following Limb Loss: PALS Plus (PALS-PLUS)
12 grudnia 2017 zaktualizowane przez: Johns Hopkins University
Limb loss can result from a variety of etiologies including diabetes, trauma and cancer.
Following limb loss, individuals are at elevated risk for activity limitations and participation restrictions with significant impact on health and quality of life.
Intervention: Working with the Amputee Coalition of America we have developed, evaluated, and established the effectiveness of a self-management program (PALS) to improve health and outcomes following limb loss.
Literature suggests that the access to, and effectiveness and utilization of, this class of interventions may be enhanced by the concerted use of early intervention, peer mentorship, motivational interviewing and provider training.
Objectives: Our goal is to evaluate the effectiveness of an enhanced, early self-management intervention- PALS Plus.
The specific aims are:1) evaluate the effectiveness of the PALS Plus intervention in improving outcomes for persons with limb loss; (2) evaluate the effectiveness of the PALS Plus intervention in maximizing utilization of self-management interventions for persons with limb loss.
A cohort of 200 patients will be enrolled prior to implementation of the intervention and will serve as the control group.
Subsequently, a second cohort of 200 patients will be enrolled and receive the PALS Plus intervention and will serve as the intervention group.
Assessment will be at baseline, treatment completion and six month follow-up.
Outcomes: Primary outcome measures are: pain, depressed mood, and positive mood.
Secondary outcome measures are: function, participation and bothersomeness of limitations.
The investigation will also provide unique and valuable information regarding patients' acceptance and use of peer visitation and self-management following limb loss.
Relevance: By establishing the utility and effectiveness of the enhanced self-management intervention, there is the potential to improve the health, activity, participation and quality of life for individuals with disabilities.
The intervention addresses the areas of activity and participation in such a way that it can be implemented in local health care facilities working in combination with a national consumer based organization - the Amputee Coalition of America.
Przegląd badań
Status
Zakończony
Warunki
Interwencja / Leczenie
Szczegółowy opis
Limb loss can result from a variety of etiologies including diabetes, trauma and cancer.
Following limb loss, individuals are at elevated risk for activity limitations and participation restrictions with significant impact on health and quality of life.
Intervention: Working with the Amputee Coalition of America we have developed, evaluated, and established the effectiveness of a self-management program (PALS) to improve health and outcomes following limb loss.
Literature suggests that the access to, and effectiveness and utilization of, this class of interventions may be enhanced by the concerted use of early intervention, peer mentorship, motivational interviewing and provider training.
Objectives: Our goal is to evaluate the effectiveness of an enhanced, early self-management intervention- PALS Plus.
The specific aims are:1) evaluate the effectiveness of the PALS Plus intervention in improving outcomes for persons with limb loss; (2) evaluate the effectiveness of the PALS Plus intervention in maximizing utilization of self-management interventions for persons with limb loss.
Study Design and Participants: The prospective clinical trial will use a two group, lagged-control design to evaluate the intervention at five health care facilities.
A cohort of 200 patients will be enrolled prior to implementation of the intervention and will serve as the control group.
Subsequently, a second cohort of 200 patients will be enrolled and receive the PALS Plus intervention and will serve as the intervention group.
Assessment will be at baseline, treatment completion and six month follow-up.
Outcomes: Primary outcome measures are: pain, depressed mood, and positive mood.
Secondary outcome measures are: function, participation and bothersomeness of limitations.
Improvements in primary and secondary outcomes will result through the impact on self efficacy, patient activation, catastrophizing and social support.
The investigation will also provide unique and valuable information regarding patients' acceptance and use of peer visitation and self-management following limb loss.
Relevance: By establishing the utility and effectiveness of the enhanced self-management intervention, there is the potential to improve the health, activity, participation and quality of life for individuals with disabilities.
The intervention addresses the areas of activity and participation in such a way that it can be implemented in local health care facilities working in combination with a national consumer based organization - the Amputee Coalition of America.
Typ studiów
Interwencyjne
Zapisy (Rzeczywisty)
400
Faza
- Faza 2
- Faza 1
Kontakty i lokalizacje
Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.
Lokalizacje studiów
-
-
Maryland
-
Baltimore, Maryland, Stany Zjednoczone, 21239
- Good Samaritan Hospital
-
-
Kryteria uczestnictwa
Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.
Kryteria kwalifikacji
Wiek uprawniający do nauki
18 lat do 85 lat (Dorosły, Starszy dorosły)
Akceptuje zdrowych ochotników
Nie
Płeć kwalifikująca się do nauki
Wszystko
Opis
Inclusion Criteria:
- Adults (aged 18-85 years) of both sexes and all races admitted to one of the seven participating acute care hospitals or rehabilitation facilities for an amputation procedure and/or treatment immediately following an amputation procedure, including traumatic amputations as well as amputations due to complications for diabetes mellitus, peripheral vascular disease, and malignancy.
- Women and minority patients will be represented in the trial according to the gender and race/ethnic prevalence of patients receiving treatment at the designated hospital and rehabilitation centers.
Exclusion Criteria:
Criteria for exclusion from the study will include:
- Age less than 18 or over 85 years; and
- Inability to communicate in written or spoken English.
Plan studiów
Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Nielosowe
- Model interwencyjny: Zadanie dla jednej grupy
- Maskowanie: Brak (otwarta etykieta)
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
|---|
|
Primary outcome measures are: pain, depressed mood, and positive mood.
|
Miary wyników drugorzędnych
Miara wyniku |
|---|
|
Secondary outcome measures are: function, participation and bothersomeness of limitations
|
Współpracownicy i badacze
Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.
Sponsor
Śledczy
- Główny śledczy: Stephen T Wegener, PHD, Johns Hopkins University
Daty zapisu na studia
Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.
Główne daty studiów
Rozpoczęcie studiów
1 marca 2007
Zakończenie podstawowe (Rzeczywisty)
1 sierpnia 2009
Ukończenie studiów (Rzeczywisty)
1 sierpnia 2009
Daty rejestracji na studia
Pierwszy przesłany
14 marca 2007
Pierwszy przesłany, który spełnia kryteria kontroli jakości
14 marca 2007
Pierwszy wysłany (Oszacować)
15 marca 2007
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
13 grudnia 2017
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
12 grudnia 2017
Ostatnia weryfikacja
1 grudnia 2017
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- CDC R01DD000153
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .